Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars C Rump

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Endocrinology|August 28, 2015
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's RegistryGregor Hanslik, Henri Wallaschofski, Anna Dietz, et al.
European Journal of Endocrinology|April 12, 2018
Primary aldosteronism: key characteristics at diagnosis: a trend toward milder formsDaniel A Heinrich, Christian Adolf, Lars C Rump, et al.
Hypertension (Dallas, Tex. : 1979)|November 6, 2013
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient miceSebastian A Potthoff, Michael Fähling, Tilman Clasen, et al.
Journal of Hypertension|March 2, 2006
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyHermann Haller, Gian C Viberti, Albert Mimran, et al.
Circulation|April 27, 2011
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot studyFelix Mahfoud, Markus Schlaich, Ingrid Kindermann, et al.
Journal of Hypertension|March 16, 2012
Prevention of microalbuminuria in patients with type 2 diabetes and hypertensionJan Menne, Joseph L Izzo, Sadayoshi Ito, et al.
Transplantation|June 29, 2017
Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized TrialWolfgang Arns, Andrea Huppertz, Thomas Rath, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2013
Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocolThilo Krueger, Georg Schlieper, Leon Schurgers, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 22, 2021
Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipientsMarta Kantauskaite, Lisa Müller, Thilo Kolb, et al.
Journal of the American Society of Nephrology : JASN|February 23, 2020
<i>α</i>2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney DiseaseLydia Hering, Masudur Rahman, Henning Hoch, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Endocrinology|August 28, 2015
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's RegistryGregor Hanslik, Henri Wallaschofski, Anna Dietz, et al.
European Journal of Endocrinology|April 12, 2018
Primary aldosteronism: key characteristics at diagnosis: a trend toward milder formsDaniel A Heinrich, Christian Adolf, Lars C Rump, et al.
Hypertension (Dallas, Tex. : 1979)|November 6, 2013
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient miceSebastian A Potthoff, Michael Fähling, Tilman Clasen, et al.
Journal of Hypertension|March 2, 2006
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyHermann Haller, Gian C Viberti, Albert Mimran, et al.
Circulation|April 27, 2011
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot studyFelix Mahfoud, Markus Schlaich, Ingrid Kindermann, et al.
Journal of Hypertension|March 16, 2012
Prevention of microalbuminuria in patients with type 2 diabetes and hypertensionJan Menne, Joseph L Izzo, Sadayoshi Ito, et al.
Transplantation|June 29, 2017
Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized TrialWolfgang Arns, Andrea Huppertz, Thomas Rath, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2013
Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocolThilo Krueger, Georg Schlieper, Leon Schurgers, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 22, 2021
Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipientsMarta Kantauskaite, Lisa Müller, Thilo Kolb, et al.
Journal of the American Society of Nephrology : JASN|February 23, 2020
<i>α</i>2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney DiseaseLydia Hering, Masudur Rahman, Henning Hoch, et al.
Pageof 7